Načítá se...
Turning the Old Adjuvant from Gel to Nanoparticles to Amplify CD8(+) T Cell Responses
Due to its safety and efficacy, aluminum hydroxide is used as an immune adjuvant in human vaccines for over 80 years. Being a Th2 stimulator, the classical gel‐like adjuvant, however, fails to generate CD8(+) T cell responses, which are important for cancer vaccines. Here, aluminum hydroxide is turn...
Uloženo v:
| Vydáno v: | Adv Sci (Weinh) |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5770685/ https://ncbi.nlm.nih.gov/pubmed/29375970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/advs.201700426 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|